ILDong Amikacin Adverse Reactions

Shock: Use of the product may rarely cause shock. Close clinical observation is required. If abnormal signs or symptoms occur, therapy should be discontinued and appropriate treatment initiated.
Hypersensitivity: Use of the product may infrequently cause rash or pruritus and rarely cause fever. If such reactions occur, therapy should be discontinued.
Neurologic: Symptoms of eighth nerve disorders such as tinnitus, a closed feeling of the ear, ear pain, vertigo and deafness may occur infrequently. Close clinical observation is required. If symptoms occur, discontinuation of therapy is desirable. If prolongation of therapy is unavoidable, the product should be administered with caution.
Renal: Severe renal disorders such as acute renal failure may occur rarely. Close clinical observation is required. If abnormal signs or symptoms occur, therapy should be discontinued and appropriate treatment initiated.
Hepatic: Elevations in GOT, GPT and/or AL-P levels may occur infrequently. Close clinical observation is required. If abnormal signs or symptoms occur, appropriate treatment including discontinuation of therapy should be initiated.
Hematologic: Symptoms such as leucopenia and eosinophilia may occur rarely.
Gastrointestinal: Symptoms such as diarrhea, nausea and vomiting may occur rarely.
Vitamin deficiencies: Symptoms of vitamin K deficiency (such as hypo-prothrombinemia and bleeding tendency) and vitamin B group deficiency (such as glossitis, stomatitis, anorexia and neuritis) may occur rarely.
Injection sites: Intramuscular use of the product may infrequently cause local pain or induration at the site of injection.
Others: Symptoms such as transient headache and numbness of the lips may occur rarely.